McKinsey & Co. pushed a judge to dismiss a bankruptcy trustee’s quest for it to pay for alleged harm it caused pharmaceutical maker Endo International Plc through its “reckless” advice on marketing and selling opioids.
Accusations that the global consulting firm and its affiliates helped destroy billions of dollars of Endo’s value must be tossed because they had no control over the company, McKinsey attorney Andrew K. Glenn of Glenn Agre Bergman & Fuentes LLP said at a hearing Thursday in the US Bankruptcy Court for the Southern District of New York.
The suit, filed in August 2024, was brought ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.